PL1.1EPIGENETICS IN ALCOHOL ADDICTION
PL3.1MEDICAL TREATMENT
PL4.1DOES ADDICTION RESEARCH NEED A PARADIGM SHIFT?
S01ALCOHOL USE DISORDER DSM V DRAFT CRITERIA
S01.2PREDICTORS OF CONTINUED DSM-V ALCOHOL DEPENDENCE INTO EARLY ADULTHOOD
S01.3THE CRAVING-WITHDRAWAL MODEL FOR ALCOHOLISM
S01.4POTENTIAL DIAGNOSTIC THRESHOLDS AND SEVERITY OF DSM V ALCOHOL USE DISORDERS
S02ALCOHOL AND THE KIDNEYS02.2ALCOHOL CONSUMPTION AND RISK OF CHRONIC KIDNEY DISEASE
S02.3ALCOHOL AND THE RISK OF RENAL CELL CANCER
S03NEUROPHYSIOLOGY OF ACETALDEHYDE
S03.2ETHANOL, ACETALDEHYDE AND DOPAMINE NEURONS
S03.3BRAIN MAPPING OF CFOS IMMUNOREACTIVITY AFTER CENTRAL AND PERIPHERAL ADMINISTRATION OF ETHANOL AND ACETALDEHYDE IN RATS
S03.4OVERVIEW OF THE BEHAVIORAL EFFECTS OF ACETALDEHYDE
S04ALCOHOL PROBLEMS IN YOUNG ADULTS TRANSITIONING FROM ADOLESCENCE TO ADULTHOOD
S04.2ADOLESCENT INTOXICATION AND ALCOHOL-RELATED COMPLICATIONS IN AMERICAN INDIAN AND MEXICAN AMERICAN YOUNG ADULTS
S04.3GENDER AND ETHNIC COMPARISON OF THE DEVELOPMENT OF PROBLEM DRINKING AMONG YOUNG ADULTS
S04.4DEVIANCE PRONENESS AS A MODEL OF ALCOHOLISM RISK
S05ALCOHOL AND INFLAMMATIONS05.1THE ROLE OF CYTOKINES IN ALCOHOLIC STEATOHEPATITIS
S05.2HEPATOPROTECTION AND IMMUNE RESPONSE TOWARDS MONOTHERAPY AND COMBINATION THERAPY WITH ANTIBODIES TO TNFα IN EXPERIMENTAL ALCOHOLIC STEATOHEPATITIS
S05.3IRON METABOLISM AND ALCOHOLIC LIVER DISEASE
S05.4H2O2
S06ROLE OF INNATE IMMUNE SYSTEM IN THE ETHANOL-INDUCED BRAIN DAMAGE, BEHAVIOURAL DYSFUNCTIONS AND ADDICTIONS06.1BINGE DRINKING INDUCES SIGNIFICANT CHANGES IN THE INNATE IMMUNE SYSTEM
S06.2THE NF-KAPPAB SYSTEM IN TRANSCRIPTIONAL CONTROL OF MALADAPTIVE AND PROTECTIVE RESPONSES IN HUMAN ALCOHOLICS
S06.3ROLE OF THE TLR4 RESPONSE IN THE NEUROINFLAMMATION, BRAIN DAMAGE AND BEHAVIOURAL DYSFUNCTIONS INDUCED BY CHRONIC ETHANOL CONSUMPTION
S06.4INDUCTION OF INNATE IMMUNE GENES BY ETHANOL CREATES THE NEUROBIOLOGY OF ADDICTION
S07COMBINED DEPENDENCE FROM ALCOHOL AND TOBACCO
S07.2THE IMPACT OF SMOKING ON THE COURSE OF ALCOHOL DEPENDENCE
S07.3SMOKING CESSATION IN ALCOHOL-DEPENDENT PATIENTS
S07.4PANCREATIC CANCER
S08ESBRA-NIAAA JOINT SYMPOSIUM ALCOHOLIC LIVER DISEASE
S08.2RISK FACTORS FOR ALCOHOLIC LIVER DISEASE
S08.3IMMUNOLOGIC FACTORS IN ALD
S08.5FIBROGENESIS IN ALCOHOLIC LIVER DISEASE
S10ADDICTIVE BEHAVIOUR
S10.2APPETITE REGULATING PEPTIDES
S10.3THE ROLE OF ETHANOL AS A STRESS/HPA AXIS CHALLENGE AND ITS MODULATION OF NEUROSTEROID LEVELS AND NEUROSTEROIDOGENIC ENZYMES IN C57BL/6J AND DBA/2J MICE
S10.4INTERACTIONS BETWEEN THE HPA- AND THE HPG-AXIS
S09ALCOHOLISM
S09.3FETAL ALCOHOL-INDUCED HYPERMETHYLATION OF PROOPIOMELANOCORTIN GENE IN THE HYPOTHALAMUS TRANSMITS THROUGH GERMLINE
S09.4EPIGENETIC MECHANISMS IN THE BRAIN OF HUMAN ALCOHOLICS
S11ALCOHOL AND THE HEARTS11.1CLINICAL OVERVIEW OF ALCOHOL EFFECTS ON THE HEART
S11.2QUANTITATIVE PROTEOMIC ANALYSIS OF ALCOHOLIC CARDIOMYOPATHY
S11.3MOLECULAR MECHANISM OF ALCOHOL-INDUCED CARDIAC DAMAGE
S12YOUNG RESEARCHER SYMPOSIUM I
S12.2GLUCOCORTICOIDS AND ALCOHOL
S12.3THE EFFECT OF NANDROLONE ON ALCOHOL DRINKING IN AA AND WISTAR RATS
S12.4LIFETIME SEX HORMONE ACTIVITY IN ALCOHOL DEPENDENCE
S13NONINVASIVE SCREENING FOR LIVER CIRRHOSIS IN ADDICTIVE PATIENTSS13.1IS LIVER STIFFNESS THE NOVEL GOLD STANDARD TO ASSESS LIVER CIRRHOSIS?
S13.2HOW USEFUL ARE SERUM MARKERS TO DETECT LIVER CIRRHOSIS IN ADDICTIVE PATIENTS?
S13.3SCREENING FOR CIRRHOSIS IN DRUG USERS BY LIVER STIFFNESS MEASUREMENT
S13.4MEASURING LIVER STIFFNESS IN A COMMUNITY-BASED POPULATION
S14IDENTIFICATION OF NEUROINFLAMMATION IN THE BRAIN IN VIVO AND IN VITRO AND THERAPEUTIC STRATEGIES TO COMBAT ITS PROGRESSIONS14.1INFLAMMATORY PROCESSES IN NEURODEGENERATIVE DISEASES
S14.2IMAGING NEUROINFLAMMATION IN ALCOHOLISM
S14.3CAN PERIPHERAL MARKERS INDICATE NEUROINFLAMMATION?
S14.4INFLAMMASOME INDUCTION REGULATES HIPPOCAMPAL NEUROGENESIS AND DEPRESSION
S15ESBRA/ISBRA JOINT SYMPOSIUM
S15.2THE DOPAMINE D2/3 RECEPTOR AGONIST RADIOLIGAND [ 11 C]-(+)-PHNO AS A TOOL FOR STUDYING ALCOHOL DEPENDENCE IN HUMANS
S15.3MULTI-MODALITY IMAGING ASSESSMENT OF ALCOHOLISM'S DAMAGING EFFECT ON BRAIN SYSTEMS AND CIRCUITRY
S16ALCOHOLIC LIVER DISEASE AND LIVER TRANSPLANTATIONS16.3RELAPSE OF HARMFUL DRINKING IN LIVER-TRANSPLANTED ALCOHOLICS
S16.4EARLY LIVER TRANSPLANTATION AS A RESCUE OPTION FOR PATIENTS WITH SEVERE ALCOHOLIC HEPATITIS NON-RESPONSIVE TO THERAPY
S17ALCOHOL AND GABAA RECEPTORSS17.1EXTRASYNAPTIC GABAA-RS
S17.2ROLE OF DELTA SUBUNIT-CONTAINING GABAA-RS IN LOW DOSE ETHANOL ACTIONS ON THE BRAIN
S17.3THE ROLE OF GABAA-R SUBTYPES IN PUTATIVE ALCOHOL-ANTAGONISTIC EFFECTS OF RO15-4513
S17.4PROTEIN KINASE C REGULATION OF ETHANOL ACTIONS AT GABAA-R
S18LESCH TYPOLOGY (LAT)
S18.2LAT
S18.3PREFRONTAL CORTEX NEUROMODULATION INDUCED BY TRANSCRANIAL DIRECT CURRENT STIMULATION AS A PROMISING APPROACH IN THE TREATMENT OF LESCH'S TYPE IV ALCOHOLISM
S18.5NEW GENETIC FINDINGS ACCORDING TO LESCH TYPOLOGY
S19ESBRA/EASL JOINT SYMPOSIUM
S19.2THERAPEUTIC APPROACHES TO EXTRAHEPATIC ALCOHOL-ASSOCIATED DISEASES
S19.5ALCOHOL AND CARCINOGENESIS
S20ESBRA-APSAAR JOINT SYMPOSIUM
S20.2THE POSSIBLE THERAPEUTIC APPROACH FOR AMELIORATION OF ALCOHOL-INDUCED BRAIN DAMAGE
S20.3CHRONIC ALCOHOL INTAKE CAUSES NEUROINFLAMMATION AND MYELIN ALTERATIONS IN MOUSE BRAIN
S20.4SYNAPTIC DYSFUNCTION IN THE BRAIN OF THE HUMAN ALCOHOLIC
S20.5PROLONGED CHANGES IN THE CNS DURING ALCOHOL ABSTINENCE
S21GENETIC DIFFERENCES AT THE SEROTONIN TRANSPORTER GENE PROMISE A PHARMACOGENETIC APPROACH TO THE USE OF ONDANSETRON WITH AND WITHOUT OTHER AGENTS TO TREAT ALCOHOLISMS21.1POLYMORPHISM OF THE SNP IN THE 3′-UNTRANSLATED REGION OF THE SEROTONIN TRANSPORTER GENE DIFFERENTIALLY AFFECT ALCOHOL CRAVING
S21.3PHARMACOGENETIC APPROACH AT THE SEROTONIN TRANSPORTER GENE AS A METHOD TO REDUCE SEVERE ALCOHOL CONSUMPTION
S21.4SEVERITY OF DRINKING AS A PREDICTOR OF EFFICACY OF THE COMBINATION OF ONDANSETRON AND TOPIRAMATE IN RAT MODELS OF ETHANOL CONSUMPTION AND RELAPSE
S22YOUNG RESEARCHER SYMPOSIUM II
S22.2HIGH CONCENTRATION OF CARCINOGENIC ACETALDEHYDE IN FERMENTED DAIRY PRODUCTS WITH AND WITHOUT PROBIOTICS
S22.3TRANSFORMING GROWTH FACTOR (TGF)-β AND ETHANOL
S22.4ALDH2 GENOTYPE HAS NO SIGNIFICANT EFFECT ON ORAL CAVITY'S EXPOSURE TO CARCINOGENIC ACETALDEHYDE AFTER RINSING THE MOUTH WITH ETHANOL
S22.5ASSOCIATION BETWEEN A POLYMORPHISM IN THE PROMOTER OF A GLUTAMATE RECEPTOR SUBUNIT GENE (GRIN2A) AND ALCOHOLISM
S23NEUROBIOLOGICAL ENDOPHENOTYPES IN ALCOHOL DEPENDENCES23.1GENETIC DETERMINANTS OF ALCOHOL ADDICTION
S23.2INFLUENCE OF CANDIDATE GENE VARIANTS ON EARLY ONSET OF DRINKING AND ALCOHOL DEPENDENCE PERTAINING TO ALCOHOL DEPENDENCE FAMILY HISTORY
S23.3IMPULSIVE BEHAVIOR IN ALCOHOL DEPENDENCE
S23.4IN A SEARCH OF ALCOHOLISM PHENOTYPES
S23.5NEUROBIOLOGY OF LEARNING DYSFUNCTION IN ALCOHOLISM
S24S-ADENOSYLMETHIONINE IN THE PATHOGENESIS AND TREATMENT OF ALCOHOLIC LIVER DISEASES24.1THE ROLE OF ALTERED SAME METABOLISM IN ALCOHOL-INDUCED ER STRESS AND LIVER INJURY
S24.2RESCUE OF ALTERED METHYLATION REACTIONS BY BETAINE
S24.3ROLE OF SAME IN HEPATOCELLULAR CARCINOMA
S24.4THE EFFECTS OF SAME ON METHIONINE METABOLISM AND TREATMENT OF ALD
SATELLITE SYMPOSIASAT1MERGING NEUROBIOLOGICAL EVIDENCE AND CLINICAL PRACTICE IN THE MANAGEMENT OF ALCOHOL DEPENDENCE (LUNDBECK)SAT1.1NEW FINDINGS ON THE NEUROBIOLOGY OF ADDICTION
SAT1.2REDUCTION IN ALCOHOL INTAKE AS A PRODUCTIVE AND ACHIEVABLE GOAL IN THE TREATMENT OF ALCOHOL PROBLEMS
SAT1.3THE BENEFITS OF REDUCTION
SAT2TREATMENT OF ALCOHOL ADDICTION
SAT2.3SCIENTIFIC RESULTS AND CLINICAL PRACTICE WITH SODIUM OXYBATE IN ALCOHOL WITHDRAWAL
SAT2.4SCIENTIFIC RESULTS AND CLINICAL PRACTICE WITH SODIUM OXYBATE IN PREVENTION OF ALCOHOL RELAPSES
FREE ORAL COMMUNICATIONS 1
O1.2TOO WHITE, TOO CHEAP, TOO FAST
O1.3BINGE DRINKING IN NATIVE ADOLESCENTS AND ADOLESCENTS WITH MIGRATION BACKGROUND LIVING IN GERMANY
O1.4ADAPTATION OF THE ALCOHOL EXPECTANCY QUESTIONNAIRE (AEQ-A)
O1.5THE IMPACT OF TEMPERAMENT, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND PSYCHOSOCIAL FACTORS ON SUBSTANCE USE AND THE MOTIVATION TO CONSUME IN YOUNG ADULT MALES
O1.6INPATIENT DETOXIFICATION AND LAW ENFORCEMENT COSTS RELATED TO ACUTE DRINKING EVENT
FREE ORAL COMMUNICATIONS 2
O2.2IS HISTOLOGY THE ‘ADEQUATE’ GOLD STANDARD TO VALIDATE THE ASSESSMENT OF ALCOHOLIC LIVER FIBROSIS BY TRANSIENT ELASTOGRAPHY (FIBROSCAN)?
O2.3ROLE OF INTESTINAL PERMEABILITY AND INFLAMMATION IN THE BIOLOGICAL AND BEHAVIORAL CONTROL OF ALCOHOL-DEPENDENT SUBJECTS
O2.4THE LOSS OF METABOLIC CONTROL ON ALCOHOL DRINKING IN HEAVILY DRINKING ALCOHOLICS
O2.5SPECIFICITY OF MACROSTRUCTURAL ABNORMALITIES IN KORSAKOFF'S SYNDROME COMPARED WITH UNCOMPLICATED ALCOHOLISM
O2.6CYTOCHROME P450 2E1 AS AN IMPORTANT FACTOR OF HEPATIC STEATOSIS AND FIBROSIS IN PATIENTS WITH ALCOHOLIC AND NON-ALCOHOLIC FATTY LIVER DISEASE
FREE ORAL COMMUNICATIONS 3
O3.2COMPARISON OF THE EFFECT OF THE POSITIVE ALLOSTERIC MODULATOR OF THE GABA(B) RECEPTOR, GS39783, ON ALCOHOL SELF-ADMINISTRATION IN THREE DIFFERENT LINES OF ALCOHOL-PREFERRING RATS
O3.3OXIDATIVE THEORY OF STRUCTURE-SPECIFIC ACTION OF ALCOHOL IN BRAIN
O3.4INVOLVEMENT OF CHROMATIN REMODELLING IN THE DEVELOPMENT OF ETHANOL-INDUCED BEHAVIORAL SENSITIZATION
O3.5INTERPRETATION OF THE CARBOHYDRATE-DEFICIENT TRANSFERRIN (CDT) ASSAY OF CIRRHOTIC PATIENTS
O3.6FRONTAL LOBE FUNCTION IN ALCOHOLICS CLASSIFIED ACCORDING TO LESCH'S TYPOLOGY
FREE ORAL COMMUNICATIONS 4
O4.2NEUROCOGNITIVE FACTORS MODERATE THE EFFECTIVENESS OF GROUP MOTIVATIONAL ENHANCEMENT THERAPY AMONG HIGH-RISK ADOLESCENTS
O4.3SEROTONERGIC, DOPAMINERGIC AND NORADRENERGIC FUNCTIONS IN ALCOHOL-DEPENDENT INDIVIDUALS
O4.4A PRACTICAL SCALE OF CLINICAL IMPRESSION AS BASIS FOR TREATMENT DECISIONS AND LONG-TERM FOLLOW-UPS OF ADDICTED PATIENTS
O4.5ACAMPROSATE FOR IMPROVING CONTROLLED DRINKING
O4.6ALCOHOLISM EFFECTS ON DIFFERENT COMPONENTS OF THEORY OF MIND
FREE ORAL COMMUNICATIONS 5
O5.2BETAINE FEEDING PREVENTS THE BLOOD ALCOHOL CYCLE IN RATS FED ALCOHOL CONTINUOUSLY FOR 1 MONTH USING THE INTRAGASTRIC TUBE FEEDING MODEL
O5.3BONE LOSS IN ALCOHOL ABUSE IS ASSOCIATED WITH OSTEOCYTE APOPTOSIS, BONE MARROW AND MICRO-VESSELS FAT INCORPORATION
O5.4ALCOHOL INTOXICATIONS DURING ADOLESCENCE INCREASE MOTIVATION FOR ALCOHOL IN ADULT RATS
O5.5PHOSPHATIDYLETHANOL IN BLOOD (B-PETH) AS A CLINICAL ALCOHOL MARKER
O5.6PROLONGED URINARY DETECTION TIMES OF ETG AND ETS IN PATIENTS WITH DECREASED RENAL FUNCTION
FREE ORAL COMMUNICATIONS 6
O6.2UNEXPECTED FACILITATION OF HIPPOCAMPAL LONG-TERM DEPRESSION OF SYNAPTIC PLASTICITY AFTER PRE- AND POSTNATAL ETHANOL EXPOSURE
O6.3PREGNANT WOMEN WHO COMPLETELY DISAVOW ALCOHOL CONSUMPTION AND DRINK DURING PREGNANCY MIGHT BE HEAVIER DRINKERS THAN THOSE ADMITTING MODERATE ETHANOL INTAKE
O6.4FORMIC ACID, THE TOXIC METABOLITE OF METHANOL, IS TOXIC TO THE PLACENTA
O6.5PREGNANCY PROTEINS IN NON-PREGNANT ALCOHOLICS
FREE ORAL COMMUNICATIONS 7
O7.2SIGNIFICANCE OF ALCOHOL USE DISORDERS IN BINGE EATING DISORDER
O7.3IMPROVEMENTS IN BALANCE IN TYPE I BUT NOT IN TYPE IV ALCOHOL-DEPENDENT PATIENTS AFTER DETOXIFICATION
O7.4TREATMENT OF ALCOHOL WITHDRAWAL SYNDROME WITH THE USE OF BODY ACUPUNCTURE ACCORDING TO THE LESCH ALCOHOLISM TYPOLOGY
O7.5DOES ACAMPROSATE IMPROVE CONTROL OF DRINKING AS WELL AS AIDING ABSTINENCE? AN INDIVIDUAL PATIENT DATA META-ANALYSIS OF 16 STUDIES
O7.6INFLUENCE OF CANDIDATE GENE VARIANTS ON EARLY ONSET OF DRINKING AND ALCOHOL DEPENDENCE PERTAINING TO ALCOHOL DEPENDENCE FAMILY HISTORY
07.7INFLUENCE OF AGE AND SEX ON ALCOHOL TOLERANCE IN ADOLESCENT BINGE DRINKERS
POSTER SESSION 1
P02DOPAMINE D2 RECEPTOR POLYMORPHISMS AND SUSCEPTIBILITY TO ALCOHOL DEPENDENCE IN KOREAN ALCOHOLICS
P03THE EFFECT OF THE SHORT-TERM TREATMENT OF ALCOHOL DEPENDENCY ON THE CINGULUM ACTIVITY
P04LOCOMOTOR SENSITIZATION AFTER REPEATED INTRATEGMENTAL INJECTIONS OF SALSOLINOL IN RATS
P05INTRATEGMENTAL INJECTION OF A LOW DOSE OF ETHANOL PRODUCES MOTOR DEPRESSION UNDER REDUCTION OF BRAIN-GENERATED ACETALDEHYDE
P06EFFECTS OF REPEATED INTRATEGMENTAL INJECTIONS OF ETHANOL ON LOCOMOTOR ACTIVITY IN RATS
P07VARIATION IN THE NEUROACTIVE STEROID SYNTHETIC ENZYME 3α-REDUCTASE TYPE 2 MODERATES SUBJECTIVE EFFECTS OF ALCOHOL
P08INVOLVEMENT OF INSULIN AND C-PEPTIDE SERUM LEVELS IN ALCOHOL WITHDRAWAL
P09REDUCTION OF ALCOHOL INTAKE, RELAPSE-LIKE DRINKING AND ANXIETY-RELATED BEHAVIORS BY GET73 IN ALCOHOL-PREFERRING SP RATS
P10GENDER INFLUENCE ON THE FORMATION OF ALCOHOL PREFERENCE AND BEHAVIOR IN RATS WITH THE LONG-TERM CAFFEINE AND ETHANOL INTAKE
P11ALCOHOL PREFERENCE FORMING DEPENDS ON INDIVIDUAL EMOTIONAL CHARACTERISTICS IN RATS
P12DEVELOPMENT OF ‘BEHAVIORAL’ DEPENDENCE ON ALCOHOL IN SARDINIAN ALCOHOL-PREFERRING RATS EXPOSED TO AN INTERMITTENT ACCESS TO 20% ALCOHOL AND WATER
P13ALPHA LIPOIC ACID PREVENTS THE ETHANOL-INDUCED CONDITIONED PLACE PREFERENCE IN MICE, A ROLE FOR H2O2 IN THE REWARDING EFFECTS OF ETHANOL
P14STIMULANT EFFECTS OF ETHANOL IN ADOLESCENT SWISS MICE
P15GABA- AND OPIOIDERGIC MODULATION OF ETHANOL SELF-ADMINISTRATION IN THE VENTRAL PALLIDUM
P16CHANGES IN HISTONE ACETYLATION IN THE PREFRONTAL CORTEX OF ETHANOL-EXPOSED ADOLESCENT RATS PROMOTE THE CONDITIONED EFFECTS OF ETHANOL
P17ROLE OF TLR4 IN THE ETHANOL-INDUCED BRAIN DAMAGE AND DEMYELINATION
P18ENDOCYTOSIS IN CULTURED NEURONS IS ALTERED BY CHRONIC ALCOHOL EXPOSURE
P19REDUCTION ON VOLITIONAL ETHANOL INTAKE PRODUCED BY MONOAMINO OXIDASE INHIBITORS
P20EFFECT OF ETHANOL ON THE EXPRESSION OF BRAIN-DERIVED NEUROTROPHIC FACTOR IN THE RAT BRAIN
P21IMPAIRMENT OF CENTRAL ACETALDEHYDE FORMATION INHIBITS PKA ACTIVATION
P22EVALUATION OF REPEATED ETHANOL ADMINISTRATION ON BEHAVIORAL AND NEUROCHEMICAL PARAMETERS
P23BLOCKADE OF INTRACELLULAR CALCIUM RELEASE WITH DANTROLENE REDUCES ETHANOL INTAKE AND ETHANOL-INDUCED LOSS OF RIGHTING REFLEX
P24ETHANOL-INDUCED CAMP-PKA ACTIVATION DEPENDS ON INTRACELLULAR CALCIUM RELEASE FROM ENDOPLASMIC RETICULUM
P26ACUTE ALCOHOL-INDUCED LIVER STEATOSIS IN FEMALE MICE
P27ALCOHOL ABUSE AND ERP COMPONENTS IN A GO/NOGO TASK USING ALCOHOL-RELATED STIMULI
P28EFFECTS OF ACUTE AND CHRONIC ETHANOL, AND ITS FIRST METABOLITE ACETALDEHYDE ON DOPAMINERGIC NEURONAL ACTIVITY IN THE VENTRAL TEGMENTAL AREA
P29ASSOCIATIONS OF CIGARETTE SMOKING AND POLYMORPHISMS IN BRAIN-DERIVED NEUROTROPHIC FACTOR AND CATECHOL-O-METHYLTRANSFERASE WITH NEUROCOGNITION IN ALCOHOL-DEPENDENT INDIVIDUALS DURING EARLY ABSTINENCE
P30THE USE OF ALCOHOL-CONTAINING MOUTHWASH LEADS TO PRODUCTION OF CARCINOGENIC ACETALDEHYDE IN THE ORAL CAVITY
P31PROMOTION OF INTERNEUROGENESIS BY NEURAL STEM CELL TRANSPLANTATION IN FASD MODEL
P32BINGE DRINKING AND/OR CHRONIC NICOTINE ADMINISTRATION ALTERS EXTRACELLULAR GLUTAMATE AND ARGININE LEVELS IN THE NUCLEUS ACCUMBENS OF ADULT MALE AND FEMALE WISTAR RATS
P33BRAIN NGF AND BDNF ALTERATIONS IN AN FASD MOUSE MODEL
INTERNAL MEDICINEP34THIAMINE DOSE FOR SUSPECTED WERNICKE ENCEPHALOPATHY?
P35EFFECT OF N-ACETYLCYSTEINE AND GLUTAMINE-BASED COMPOSITION ON ALCOHOL-INDUCED METABOLIC AND MORPHOLOGIC LIVER INJURIES
P36EFFECT OF GLUTAMINE AND N-ACELYLCYSTEINE ON THE SYSTEMS OF ALCOHOL AND ALDEHYDE METABOLISMS IN THE LIVER OF RATS FOLLOWING ALCOHOL INTOXICATION
P37CHRONIC ETHANOL CONSUMPTION STIMULATES DIETHYLNITROSAMINE-INITIATED HEPATIC CARCINOGENESIS
P38ENHANCED GENERATION OF CARCINOGENIC DNA LESIONS IN RATS FED A HIGH FAT CHOLINE, METHIONINE-DEFICIENT DIET
P39HISTOLOGICAL DETERMINANTS OF INCREASED LIVER STIFFNESS IN ALCOHOLIC LIVER DISEASE
P40CORRECTION OF METABOLIC DISTURBANCES BY COMBINATION OF URSODEOXYCHOLIC AND OMEGA-3 POLYUNSATURATED FATTY ACIDS IN RATS WITH ALCOHOLIC STEATOHEPATITIS
P41EFFECT OF MERCASOLYL-INDUCED HYPOTHYROIDISM ON ETHANOL OXIDATION RATE AND ANTIOXIDANT STATUS IN THE LIVER OF RATS WITH CHRONIC ALCOHOL INTOXICATION
P42ALCOHOLIC PATIENTS VALUED FOR LIVER TRANSPLANT
P43EFFECT OF GLUTAMINE-CONTAINING DIPEPTIDES ON THE LEVEL OF VOLUNTARY ETHANOL CONSUMPTION IN RATS
P44HISTONE DEACETYLASE INHIBITOR IN A MODEL OF ALCOHOL DEPENDENCE
P45INDIVIDUAL DIFFERENCES IN BLOOD ALCOHOL CONCENTRATIONS AFTER MODERATE DRINKING ARE INFLUENCED BY BOTH THE GASTRIC EMPTYING RATE AND DISTRIBUTION VOLUME
P46ETHANOL CONCENTRATIONS OF PROBIOTIC AND BASIC DAIRY PRODUCTS
P47ALTERATIONS TO LIVER ENERGY METABOLISM AND CELL DEATH FOLLOWING ALCOHOL EXPOSURE
P48EFFECT OF GLUTAMINE-CONTAINING DIPEPTIDES ON THE LEVELS OF BRAIN TISSUE AMINO ACIDS DURING ACUTE ALCOHOL INTOXICATION IN RATS
POSTER SESSION 2
P50DRD2 TAQIA POLYMORPHISMS ARE ASSOCIATED WITH PERSONALITY TRAITS THAT CORRELATE WITH ALCOHOL CRAVING IN ALCOHOL-DEPENDENT SUBJECTS
P51AUDITORY EVENT RELATED POTENTIALS (P3) AND COGNITIVE CHANGES INDUCED BY FRONTAL DIRECT CURRENT STIMULATION IN ALCOHOLICS ACCORDING TO LESCH ALCOHOLISM TYPOLOGY
P52DYSFUNCTION OF GLUTAMATERGIC PROJECTION NEURONS IN THE MEDIAL PREFRONTAL CORTEX OF RATS WITH A HISTORY OF ALCOHOL DEPENDENCE
P53BIDIRECTIONAL HIPPOCAMPAL SYNAPTIC PLASTICITY IS DIFFERENTLY AFFECTED BY ETHANOL DURING BINGE DRINKING IN ADOLESCENT RAT
P54ALCOHOL-DEPENDENT PATIENTS WITH REPEAT ADMISSIONS
P55MORPHOFUNCTIONAL INDICES OF RAT BRAIN HISTAMINERGIC NEURONS IN AN HOUR AFTER SINGLE INTRAPERITONEAL INTRODUCTION OF ALCOHOL
P56EPIGENETIC DIFFERENCES IN THE PROMOTER REGION OF THE GHRELIN RECEPTOR BETWEEN HIGH AND LOW ALCOHOL-CONSUMING RATS
P58ASSESSING VIGILANCE WITH DYNAMIC PUPILLOMETRY IN PATIENTS WITH ALCOHOL DEPENDENCY
P60ALCOHOLIC HABITS DURING PREGNANCY
PSYCHIATRYP61DIMENSIONS AND CATEGORIES OF DSM V CRITERIA IN AN INTERNATIONAL SAMPLE OF DRINKING SUBJECTS AND INPATIENT ALCOHOL-DEPENDENT INDIVIDUALS
P62APPLICATION OF LESCH TYPOLOGY AT AN ALCOHOL OUTPATIENT CLINIC
P63CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF MEN AND WOMEN WITH THE HISTORY OF ALCOHOL WITHDRAWAL SEIZURES AND DELIRIUM TREMENS
P64BRAIN MORPHOLOGY AT ENTRY INTO TREATMENT FOR ALCOHOL DEPENDENCE IS ASSOCIATED WITH RELAPSE PROPENSITY
P65EXECUTIVE FUNCTION AMONG BINGE-DRINKING COLLEGE STUDENTS
P66EPISODIC MEMORY AMONG BINGE-DRINKING COLLEGE STUDENTS
P67ADHD ASSOCIATED WITH SUBSTANCE ABUSE DISORDERS IN AN ADULT INPATIENT POPULATION
P68LIFETIME PREVALENCE OF SUICIDAL-RELATED BEHAVIORS AND ITS RELATIONSHIP WITH ALCOHOL USE PROBLEMS IN CHUNGCHEONGNAM-DO PROVINCE, REPUBLIC OF KOREA
P69THE CROSS-MODAL PROCESSING OF EMOTIONAL FACE-VOICE PAIRS IS SERIOUSLY IMPAIRED IN ALCOHOL-DEPENDENCE
P70BINGE DRINKING, ALCOHOL-RELATED INJURIES AND UNSAFE SEX
LP1THE FIRST STRATIFICATION OF REGISTERED ALCOHOLIC PATIENTS IN SERBIA ACCORDING TO LESCH TYPOLOGY
TREATMENTP71PHARMACOLOGICAL TREATMENT STRATEGIES IN ALCOHOL DETOXIFICATION AND RELAPSE PREVENTION
P72THE EFFECTIVENESS OF CONTINUOUS GROUP THERAPY FOR OUTPATIENTS WITH ALCOHOL DEPENDENCE; 77-MONTH OUTCOMES
P73ATTENDANCE AND EFFECTIVENESS OF SELF-HELP GROUPS AND PSYCHOTHERAPY IN SUBSTANCE USE DISORDERS PATIENTS' ASSESSMENT
P74PHASE 1 (FIRST-IN-HUMAN) STUDIES OF GET73, A NEW CHEMICAL ENTITY FOR THE TREATMENT OF ALCOHOLISM
P75BEHAVIORAL PROFILE OF 4-TRIFLUOROMETHYL BENZYL-4-METHOXY BUTYRAMIDE (GET73), A NOVEL COMPOUND THAT REDUCES THE ALCOHOL INTAKE
P76COGNITIVE REMEDIATION THERAPY IN ALCOHOL DEPENDENCE
P77MANUALIZED PSYCHOEDUCATION TAILORED TO THE NEEDS OF ALCOHOL ADDICTS DURING DETOXIFICATION IN ORDER TO INCREASE FURTHER HEALTH-CARE UTILIZATION
P78VIEW OF DOCTORS AND PATIENTS ABOUT DEPENDENCE TREATMENT HELP IN LATVIA
P79THE EFFECTS OF ALCOHOL ON THE SUBJECTIVE AND BEHAVIOURAL RESPONSES TO NICOTINE-CONTAINING AND DENICOTINIZED TOBACCO IN DEPENDENT AND NON-DAILY SMOKERS
P80ALPE ADRIA REPORT 2010
AUTHOR INDEX
KEYWORD INDEX
FINAL PROGRAMME